Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis

Diagnosing cystic fibrosis (CF) when sweat chloride is not in the CF range and less than 2 disease-causing CFTR mutations are found requires physiological CFTR assays, which are not always feasible or available. We developed a new physiological CFTR assay based on the morphological differences betwe...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 76; no. 11; pp. 1146 - 1149
Main Authors Cuyx, Senne, Ramalho, Anabela Santo, Corthout, Nikky, Fieuws, Steffen, Fürstová, Eva, Arnauts, Kaline, Ferrante, Marc, Verfaillie, Catherine, Munck, Sebastian, Boon, Mieke, Proesmans, Marijke, Dupont, Lieven, De Boeck, Kris, Vermeulen, François
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Thoracic Society 01.11.2021
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Diagnosing cystic fibrosis (CF) when sweat chloride is not in the CF range and less than 2 disease-causing CFTR mutations are found requires physiological CFTR assays, which are not always feasible or available. We developed a new physiological CFTR assay based on the morphological differences between rectal organoids from subjects with and without CF. In organoids from 167 subjects with and 22 without CF, two parameters derived from a semi-automated image analysis protocol (rectal organoid morphology analysis, ROMA) fully discriminated CF subjects with two disease-causing mutations from non-CF subjects (p<0.001). ROMA, feasible at all ages, can be centralised to improve standardisation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0040-6376
1468-3296
1468-3296
DOI:10.1136/thoraxjnl-2020-216368